Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:15:31.968Z.
Consensus retrieved: 2026-10-06T08:18:07.029Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:15:31.968Z.
Quote observation: 2026-10-06T15:15:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c856baf2af26ca9326fa79b8c43a58fbb1378fdf70f4049426595b89831cd0b
Forward PE Ratio (N/A) = Dated Quote Price ($11.04) / Consensus Forward EPS ($-0.80)
FORWARD PE RATIO
N/A
Absci Corporation
Market Cap
$1.87B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Absci Corporation (ABSI) | $1.87B | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 64.35 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | N/A |
| Novocure Ltd (NVCR)vs › | $1.84B | N/A |
| Novavax, Inc. (NVAX)vs › | $1.90B | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 26.52 |
| Azenta, Inc. (AZTA)vs › | $1.91B | 83.33 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 27.71 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.95B | 81.96 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $11.04, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.80 | $-0.90 – $-0.75 | 6 | n/m |
| 2027-12-31 | $-0.72 | $-1.09 – $-0.34 | 6 | n/m |
| 2028-12-31 | $-0.57 | $-0.91 – $0.25 | 7 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
